Showing results (341-350 of 413) with videos related to

Sort By:
Pageof 42
Radiology|September 18, 2008
Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial resultsConstantinos T Sofocleous, Rodrigo G Nascimento, Lydia M Petrovic, et al.
Virchows Archiv : an International Journal of Pathology|August 10, 2005
Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus studyToru Furukawa, Günter Klöppel, N Volkan Adsay, et al.
Human Pathology|December 31, 2016
Diagnosing colorectal medullary carcinoma: interobserver variability and clinicopathological implicationsLik Hang Lee, Rhonda K Yantiss, Eran Sadot, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 23, 2016
Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinomaLik Hang Lee, Marcela S Cavalcanti, Neil H Segal, et al.
Neuroendocrinology|October 1, 2020
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical CorrelationsHege Elvebakken, Aurel Perren, Jean-Yves Scoazec, et al.
Human Pathology|March 18, 2008
Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significanceJinru Shia, David S Klimstra, James R Nitzkorski, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 31, 2021
Pancreatoblastomas and mixed and pure acinar cell carcinomas share epigenetic signatures distinct from other neoplasms of the pancreasJamal K Benhamida, Monika Vyas, Atsushi Tanaka, et al.
Plos One|July 14, 2012
A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkersJordan M Winter, Laura H Tang, David S Klimstra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumorsArchie N Tse, David S Klimstra, Mithat Gonen, et al.
International Journal of Cancer|July 17, 2020
Diagnosis of digestive system tumoursMary Kay Washington, Richard M Goldberg, George J Chang, et al.
Pageof 42